The impact of integrated HIV care on patient health outcomes
- PMID: 19318998
- PMCID: PMC3108041
- DOI: 10.1097/MLR.0b013e31819432a0
The impact of integrated HIV care on patient health outcomes
Abstract
Background: Control of viral replication through combination antiretroviral therapy (cART) improves patient health outcomes. Yet many HIV-infected patients have comorbidities that pose social and clinical barriers to achieving viral suppression. Integration of subspecialty services into HIV primary care may overcome such barriers.
Objective: To evaluate effect of integrated HIV care (IHC) on suppression of HIV replication.
Research design: A retrospective cohort study of HIV patients from 5 Veterans Affairs healthcare facilities 2000 to 2006.
Subjects: Patients with >3 months of follow-up, sufficient baseline HIV severity, on cART.
Measures: We measured and ranked Integrated Care at the facilities. These rankings were applied to patient visits to form an index of IHC utilization. We evaluated effect of IHC utilization on likelihood of achieving viral suppression while on cART, controlling for demographic and clinical factors using survival analysis.
Results: : The 1018 HIV-infected patients eligible for analysis had substantial barriers to responding to cART: 93% had comorbidities with mean 3.2 comorbidities per patient (SD = 2.0); 52% achieved viral suppression in median 231 days (SD = 411.6). Patients visiting clinics that offered hepatitis, psychiatric, psychologic, and social services in addition to HIV primary care were 3.1 times more likely to achieve viral suppression than patients visiting clinics which offered only HIV primary care (hazard ratio = 3.1, P < 0.001).
Conclusions: Patients who visited IHC clinics were more likely to achieve viral suppression while on cART. Future research should investigate which elements of Integrated Care are most associated with viral control and what role provider experience plays in this association.
Figures
Similar articles
-
Association between prescription cost sharing and adherence to initial combination antiretroviral therapy in commercially insured antiretroviral-naïve patients with HIV.J Manag Care Pharm. 2012 Mar;18(2):129-45. doi: 10.18553/jmcp.2012.18.2.129. J Manag Care Pharm. 2012. PMID: 22380472 Free PMC article.
-
The HIV-Brazil cohort study: design, methods and participant characteristics.PLoS One. 2014 May 1;9(5):e95673. doi: 10.1371/journal.pone.0095673. eCollection 2014. PLoS One. 2014. PMID: 24789106 Free PMC article.
-
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection.Hepatol Int. 2019 Jul;13(4):431-439. doi: 10.1007/s12072-019-09953-4. Epub 2019 Jun 8. Hepatol Int. 2019. PMID: 31177505
-
[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Enferm Infecc Microbiol Clin. 2011. PMID: 21388714 Spanish.
-
Integrated Care Models: HIV and Substance Use.Curr HIV/AIDS Rep. 2023 Oct;20(5):286-295. doi: 10.1007/s11904-023-00667-9. Epub 2023 Sep 12. Curr HIV/AIDS Rep. 2023. PMID: 37698755 Free PMC article. Review.
Cited by
-
Hypertension among persons living with HIV-Zambia, 2021; A cross-sectional study of a national electronic health record system.PLOS Glob Public Health. 2023 Jul 10;3(7):e0001686. doi: 10.1371/journal.pgph.0001686. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37428721 Free PMC article.
-
Examining the Association Between a Modified Quan-Charlson Comorbidity Index and HIV Viral Suppression: A Cross-Sectional Analysis of DC Cohort Participants.AIDS Res Hum Retroviruses. 2023 Dec;39(12):662-670. doi: 10.1089/AID.2022.0186. Epub 2023 Jul 27. AIDS Res Hum Retroviruses. 2023. PMID: 37392022
-
Integrated Care as a Model for Interprofessional Disease Management and the Benefits for People Living with HIV/AIDS.Int J Environ Res Public Health. 2023 Feb 15;20(4):3374. doi: 10.3390/ijerph20043374. Int J Environ Res Public Health. 2023. PMID: 36834069 Free PMC article. Review.
-
Ageing with HIV: Medicine Optimisation Challenges and Support Needs for Older People Living with HIV: A Systematic Review.Drugs Aging. 2023 Mar;40(3):179-240. doi: 10.1007/s40266-022-01003-3. Epub 2023 Jan 20. Drugs Aging. 2023. PMID: 36670321 Free PMC article.
-
Prevalence of Physical Health, Mental Health, and Disability Comorbidities among Women Living with HIV in Canada.J Pers Med. 2022 Aug 6;12(8):1294. doi: 10.3390/jpm12081294. J Pers Med. 2022. PMID: 36013243 Free PMC article.
References
-
- Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–860. - PubMed
-
- Barlett JA, Fath MJ, DeMasi R, et al. An updated systematic overview of triple combination therapy in antiretroviral-naïve HIV-infected adults. AIDS. 2006;20:2051–2064. - PubMed
-
- Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11–19. - PubMed
-
- Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med. 2007;146:87–95. - PubMed
-
- Howard AA, Arnsten JH, Lo Y, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002;16:2175–2182. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
